Literature DB >> 22705362

The radiosensitivity of endothelial cells isolated from human breast cancer and normal tissue in vitro.

Moon-Taek Park1, Eun-Taex Oh, Min-Jeong Song, Woo-Jean Kim, Young Up Cho, Sei Joong Kim, Jee-Young Han, Jun-Kyu Suh, Eun Kyung Choi, Byung Uk Lim, Chang Won Song, Heon Joo Park.   

Abstract

We developed a novel method for harvesting endothelial cells from blood vessels of freshly obtained cancer and adjacent normal tissue of human breast, and compared the response of the cancer-derived endothelial cells (CECs) and normal tissue-derived endothelial cells (NECs) to ionizing radiation. In brief, when tissues were embedded in Matrigel and cultured in endothelial cell culture medium (ECM) containing growth factors, endothelial cells grew out of the tissues. The endothelial cells were harvested and cultured as monolayer cells in plates coated with gelatin, and the cells of 2nd-5th passages were used for experiments. Both CECs and NECs expressed almost the same levels of surface markers CD31, CD105 and TEM-8 (tumor endothelial marker-8), which are known to be expressed in angiogenic endothelial cells, i.e., mitotically active endothelial cells. Furthermore, both CECs and NECs were able to migrate into experimental wound in the monolayer culture, and also to form capillary-like tubes on Matrigel-coated plates. However, the radiation-induced suppressions of migration and capillary-like tube formations were greater for CECs than NECs from the same patients. In addition, in vitro clonogenic survival assays demonstrated that CECs were far more radiosensitive than NECs. In summary, we have developed a simple and efficient new method for isolating endothelial cells from cancer and normal tissue, and demonstrated for the first time that endothelial cells of human breast cancer are significantly more radiosensitive than their normal counterparts from the same patients.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22705362     DOI: 10.1016/j.mvr.2012.06.002

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  6 in total

1.  Longitudinal Preclinical Imaging Characterizes Extracellular Drug Accumulation After Radiation Therapy in the Healthy and Leukemic Bone Marrow Vascular Microenvironment.

Authors:  Jamison Brooks; Darren Zuro; Joo Y Song; Srideshikan Sargur Madabushi; James F Sanchez; Chandan Guha; Marcin Kortylewski; Bihong T Chen; Kalpna Gupta; Guy Storme; Jerry Froelich; Susanta K Hui
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-11-09       Impact factor: 8.013

2.  Ionizing radiation promotes the acquisition of a senescence-associated secretory phenotype and impairs angiogenic capacity in cerebromicrovascular endothelial cells: role of increased DNA damage and decreased DNA repair capacity in microvascular radiosensitivity.

Authors:  Zoltan Ungvari; Andrej Podlutsky; Danuta Sosnowska; Zsuzsanna Tucsek; Peter Toth; Ferenc Deak; Tripti Gautam; Anna Csiszar; William E Sonntag
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-05-20       Impact factor: 6.053

Review 3.  Functional properties of ion channels and transporters in tumour vascularization.

Authors:  Alessandra Fiorio Pla; Luca Munaron
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

4.  Involvement of breast cancer stem cells in tumor angiogenesis.

Authors:  Yu Wang; Chen Li; Yuqiang Li; Zhitu Zhu
Journal:  Oncol Lett       Date:  2017-10-20       Impact factor: 2.967

5.   Generation of low-flux X-ray micro-planar beams and their biological effect on a murine subcutaneous tumor model.

Authors:  Zhengshan Hong; Junko Zenkoh; Biao Le; Ariungerel Gerelchuluun; Kenshi Suzuki; Takashi Moritake; Masakazu Washio; Junji Urakawa; Koji Tsuboi
Journal:  J Radiat Res       Date:  2015-07-03       Impact factor: 2.724

6.  Tumour Vascular Shutdown and Cell Death Following Ultrasound-Microbubble Enhanced Radiation Therapy.

Authors:  Ahmed El Kaffas; Mehrdad J Gangeh; Golnaz Farhat; William Tyler Tran; Amr Hashim; Anoja Giles; Gregory J Czarnota
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.